IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. - Test2 - elhamkhani - TriplyDB

IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.

IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.

http://www.wikidata.org/entity/Q34391196

about

Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice Human IgG4: a structural perspective Nanoparticulate adjuvants and delivery systems for allergen immunotherapy Causes and risk factors for anaphylaxis Anaphylaxis: opportunities of stratified medicine for diagnosis and risk assessment Non-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease.IgE Antibody Detection and Component Analysis in Patients with Eosinophilic Esophagitis FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma Increased susceptibility of 129SvEvBrd mice to IgE-Mast cell mediated anaphylaxis.Suppression of IgE B cells and IgE binding to Fc(epsilon)RI by gene therapy with single-chain anti-IgE.Enteric reovirus infection stimulates peanut-specific IgG2a responses in a mouse food allergy model.In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses.A beneficial role for immunoglobulin E in host defense against honeybee venom.Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.Immunization with Hypoallergens of shrimp allergen tropomyosin inhibits shrimp tropomyosin specific IgE reactivity Induction of allergic responses to peanut allergen in sheep.IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity.Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis.Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.A convenient and sensitive allergy test: IgE crosslinking-induced luciferase expression in cultured mast cells Mouse and human neutrophils induce anaphylaxis.Ingested allergens must be absorbed systemically to induce systemic anaphylaxis.Rapid polyclonal desensitization with antibodies to IgE and FcεRIα IgG1 protects against renal disease in a mouse model of cryoglobulinaemia Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis.IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.Cutaneous exposure to agglomerates of silica nanoparticles and allergen results in IgE-biased immune response and increased sensitivity to anaphylaxis in mice.Induction and suppression of allergic diarrhea and systemic anaphylaxis in a murine model of food allergy.Intestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice Molecular and cellular mechanisms of food allergy and food tolerance.Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation.Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.IgE antibodies, FcεRIα, and IgE-mediated local anaphylaxis can limit snake venom toxicity.Food allergy in mice is modulated through the thymic stromal lymphopoietin pathway.The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis Dietary medium-chain triglycerides promote oral allergic sensitization and orally induced anaphylaxis to peanut protein in mice Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy.Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization.

P2860

Q21134766-C7BD1156-862F-41D4-BAB1-CF2E2B6CE73F Q26779758-B0CE2FC2-7C1E-441A-8091-8C0834BBE449 Q26825418-1D57D3F0-CB02-4B61-88FA-3ABD1F8322A4 Q27009246-E218CA14-F24D-4942-840D-1810E995ED54 Q27023498-F75653C3-6252-409A-8F99-E36A62D5A9A0 Q30249078-2A0B9DB5-0FE7-45F1-8F0B-7C2FE3F63666 Q30279141-81D64F6B-B186-4225-A83E-C8DBF1572470 Q33533776-3BDDC818-E136-4488-A80E-A4E5F6805C56 Q33811289-30766448-E72F-495F-AA22-4B0C76CA21BC Q33870977-7638FB11-0072-4288-B098-0C4319D2CC1B Q34014468-086AED2A-4BFA-48BA-A96B-15724652DD52 Q34023674-B1AB1BC3-D629-4D1D-BB22-EAF544C1AB03 Q34110525-A33F6095-DCE9-4458-8228-441E78135393 Q34182028-C39929EC-81DE-4377-B092-FA5CC641D97A Q34402672-E9977E39-CC90-4C52-82B4-7816A6F29D12 Q34445626-12E197B3-1710-4869-A5B4-60F249DFA58B Q34531827-97BDCE14-024B-454F-B461-3895C8AF0221 Q34589849-387356EB-F324-479C-969E-38C3DAB3955D Q34653064-C35A95F1-AB63-4B1F-9D8A-7F018F060774 Q34664144-FEB95174-81C1-4B47-95F4-4FF826892587 Q34734036-7EB287DA-FD0E-44F9-9419-1E8E8E77D33F Q34755391-97EA56D9-A9D8-41C6-BFC1-1AE68DB7E987 Q34985195-0A8DECBA-D68A-4F3A-9454-44A054EC6D2D Q35125056-2D315CD5-C222-4302-808C-989296877CC9 Q35127662-5164E1CE-BE7A-4909-8637-074FE9B141CD Q35134181-AA9F96D3-0187-489F-A496-7C6373B62B55 Q35566586-FDFBCF92-E6E5-4A53-B5F2-A9CB87022AF5 Q35786805-E9160ACF-A2EF-4965-91EC-EA19F65F223C Q35954624-1EAF001E-E08F-4FD9-BE2A-706374952918 Q35967018-3E0574F5-EB40-4146-8F31-B085EC84B796 Q35984123-EED0EAA8-E3FB-42C6-849C-0AF956F762A1 Q36056484-B6EDB76B-6D70-414A-B194-30E08A2E885F Q36229572-E32DF3EF-C5EE-4068-950E-9A44A683383D Q36380184-FCA27A62-D1CE-45AF-A970-44995BF1A633 Q36469735-E6CC3A15-389C-4640-A26B-1D63D23F840B Q36481826-2DCA6D01-7F8C-4528-A927-61B5601C778A Q36509214-6844898F-E0B5-4900-B45E-1D5BFBEAF568 Q36586048-34B0CCAA-8DD5-424E-AF5E-16FD15F14714 Q36795677-002ABAAE-8820-4B7A-836B-2CEFEB69C3D9 Q37173058-C3976F12-D0DA-4A9D-87DA-F8434127EBDD

P2860

IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.

http://www.wikidata.org/entity/Q34391196

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@ast

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@en

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@nl

type

label

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@ast

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@en

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@nl

prefLabel

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@ast

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@en

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@nl

P1433

Q34391196-2D03C0F9-6BD9-47EF-87B1-A6FC7CB31527

P1476

Q34391196-892486F1-BF48-4C10-B58A-3FDE0E8E2641

P2093

Q34391196-4D415382-B141-4E32-B4FC-03A9F21D9C20

Q34391196-7A21D026-E029-4396-9223-0F4672771E5D

Q34391196-D331B5A5-63A2-4353-ABB3-9F7AA408E54F

P2860

Q34391196-032AA3F0-077B-4818-A3A1-013DA6FB01A5

Q34391196-07A9C388-6F4D-4E12-9C75-846F5CE1BF46

Q34391196-0B9889C6-661E-4CC9-B305-6095B2DB981B

Q34391196-0FEA0CBA-AD2B-4F4E-9326-79BF847DF479

Q34391196-1219B792-1489-46C3-8108-87D2941C459B

Q34391196-1C066FCE-9F69-4C82-AE96-6E44C18563C9

Q34391196-1C3082D4-A695-46F4-8098-BB8EF1C42672

Q34391196-1C600499-5F35-4AE6-9D98-E9E28E2D4E18

Q34391196-1C92A1CD-E7B7-49A2-AC4F-381F0178EB4C

Q34391196-2C34FB3B-CA90-4822-B63D-9C22B4DAF20C

P304

Q34391196-90882DE2-FFB3-4F3E-92D7-42D327688B3A

P31

Q34391196-D50AA8FC-924E-4B23-BF78-A3032B0CB6A6

P356

Q34391196-CB5F873C-8EEF-4C7D-92A1-AD1A803C6E6D

P407

Q34391196-62BBDA0D-8DD1-4819-A2F1-8D573D900734

P433

Q34391196-2D1B8E61-403E-4943-A44E-A1602E802551

P478

Q34391196-0A225643-5535-41CA-9D6F-5BB0A94A97C8

P577

Q34391196-B7E2BD71-ED11-4002-A41B-D505479C849F

P698

Q34391196-937DB66B-35A7-4613-8697-0F93F2E85F52

P921

Q34391196-3B7BE687-D07A-4E03-9282-460549C17592

Q34391196-CD98A138-DDB2-4679-970B-6F5BC3740AF5

P932

Q34391196-2561A664-9BFB-465B-B404-94B2CF297C79

P356

P1433

Journal of Clinical Investigation

P1476

IgG-blocking antibodies inhibi ...... d Fc gamma RIIb cross-linking.

@en

P2093

Fred D Finkelman

http://www.w3.org/2001/XMLSchema#string

Richard T Strait

http://www.w3.org/2001/XMLSchema#string

Suzanne C Morris

http://www.w3.org/2001/XMLSchema#string

P2860

Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice

Active anaphylaxis in IgE-deficient mice

The potential of peptide immunotherapy in allergy and asthma.

Renaissance of the blocking antibody concept in type I allergy.

Genetically engineered negative signaling molecules in the immunomodulation of allergic diseases.

Targeting the IgE molecule in allergic and asthmatic diseases: review of the IgE molecule and clinical efficacy.

Molecular mechanisms of anaphylaxis: lessons from studies with murine models.

Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors

Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG.

Basophils initiate IL-4 production during a memory T-dependent response.

P304

833-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI25575

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16498503

http://www.w3.org/2001/XMLSchema#string

P921

P932

1378186

http://www.w3.org/2001/XMLSchema#string